AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30338365 — intervention group
Group type: COMPARATOR
Intervention: DS-DECT
Number of subjects: 102
Study 28490322 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Game Therapy (VGT)
Number of subjects: 21
Study 28490322 — intervention group
Group type: COMPARATOR
Intervention: Balance Platform Therapy (BPT)
Number of subjects: 21
Study 25155201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozil® mode
Number of subjects: 150
Study 25155201 — intervention group
Group type: COMPARATOR
Intervention: US mode
Number of subjects: 150
Study 23499982 — intervention group
Group type: EXPERIMENTAL
Intervention: The Blue Dog intervention (dog bite prevention and education program)
Number of subjects: 0
Study 23499982 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21146460 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 909 vaccine
Number of subjects: 0
Study 21146460 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 21146460 — intervention group
Group type: COMPARATOR
Intervention: Ty21a vaccine
Number of subjects: 0
Study 19534641 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ppm inspired NO
Number of subjects: 15
Study 19534641 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ppm inspired NO
Number of subjects: 15
Study 19534641 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspired NO (5 ppm and 20 ppm)
Number of subjects: 15
Study 19534641 — intervention group
Group type: COMPARATOR
Intervention: Control (no NO gas)
Number of subjects: 15
Study 16776759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser irradiation (1.5 W, 15 Hz, four times for 5 s)
Number of subjects: 0
Study 16776759 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect laser treatment (through a 1-mm-thick dentine disc)
Number of subjects: 0
Study 16776759 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct laser treatment
Number of subjects: 0
Study 15338792 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure (PM10 300 microg/m3)
Number of subjects: 15
Study 15338792 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (control)
Number of subjects: 15
Study 10648669 — intervention group
Group type: EXPERIMENTAL
Intervention: Meltspun cellulose diacetate
Number of subjects: 159
Study 10648669 — intervention group
Group type: COMPARATOR
Intervention: High-flux polysulfone
Number of subjects: 159
Study 10648669 — intervention group
Group type: COMPARATOR
Intervention: Low-flux polysulfone
Number of subjects: 159
Study 10648669 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of disease state (APACHE III score)
Number of subjects: 159
Study 9262037 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrachlorodecaoxide (TCDO), 10 ml, twice daily, swish and swallow, for 7 days
Number of subjects: 62
Study 9262037 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrachlorodecaoxide (TCDO)
Number of subjects: 62
Study 9262037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 8281391 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomographic radionuclide ventriculography
Number of subjects: 100
Study 8281391 — intervention group
Group type: COMPARATOR
Intervention: Planar imaging
Number of subjects: 100
Study 8281391 — intervention group
Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 100
Study 2882626 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 1.5 g/day
Number of subjects: 505
Study 2882626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 505
Study 29355409 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CAMBRA treatment
Number of subjects: 460
Study 29355409 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 460
Study 27631750 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrogative reminders (with or without reference to social context)
Number of subjects: 48091
Study 27631750 — intervention group
Group type: COMPARATOR
Intervention: Noninterrogative reminders (with or without social context)
Number of subjects: 48091
Study 27631750 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 48091
Study 24196274 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal replacements (MRs)
Number of subjects: 48
Study 24196274 — intervention group
Group type: COMPARATOR
Intervention: Conventional reduced-fat diet (CD)
Number of subjects: 48
Study 22825497 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient and probiotic yogurt (A)
Number of subjects: 21
Study 22825497 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient alone yogurt (B)
Number of subjects: 21
Study 22825497 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic alone yogurt (C)
Number of subjects: 21
Study 22825497 — intervention group
Group type: EXPERIMENTAL
Intervention: All yogurt types
Number of subjects: 21
Study 20516672 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet medication
Number of subjects: 185
Study 20516672 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 185
Study 20516672 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke patients
Number of subjects: 185
Study 18484595 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan at a dose of 65 mg/m(2) plus cisplatin at a dose of 30 mg/m(2) (Arm A)
Number of subjects: 146
Study 18484595 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine at a dose of 900 mg/m(2) plus vinorelbine at a dose of 25 mg/m(2) (Arm B)
Number of subjects: 146
Study 18484595 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus cisplatin (IP)
Number of subjects: 146
Study 18484595 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus vinorelbine (GV)
Number of subjects: 146
Study 15911237 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa, 6.75 mug/kg, administered once every 3 weeks (asynchronous on day 15)
Number of subjects: 81
Study 15911237 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa, 6.75 mug/kg, administered once every 3 weeks (synchronous on day 1)
Number of subjects: 81
Study 15911237 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (both groups)
Number of subjects: 81
Study 15911237 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (synchronous administration)
Number of subjects: 81
Study 12891541 — intervention group
Group type: EXPERIMENTAL
Intervention: Heater probe plus thrombin
Number of subjects: 247
Study 12891541 — intervention group
Group type: COMPARATOR
Intervention: Heater probe plus placebo
Number of subjects: 247
Study 10551056 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane inhalation via nasal hood
Number of subjects: 24
Study 10551056 — intervention group
Group type: COMPARATOR
Intervention: Midazolam and fentanyl intravenous sedation followed by propofol infusion
Number of subjects: 24
Study 9051504 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 mm tunnel incision
Number of subjects: 50
Study 9051504 — intervention group
Group type: COMPARATOR
Intervention: 6.0 mm corneoscleral incision
Number of subjects: 50
Study 1947515 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as actually received
Number of subjects: 0
Study 1947515 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to treat analysis
Number of subjects: 0
Study 1947515 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 6416259 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin
Number of subjects: 193
Study 6416259 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold Sodium Thiomalate (GST)
Number of subjects: 193
Study 6416259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 31373890 — intervention group
Group type: COMPARATOR
Intervention: Conventional RBCs (Filtek Z350, Tetric N Ceram, Beautifil II)
Number of subjects: 10
Study 31373890 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill restorative RBCs (Filtek Bulk-Fill Restorative, Tetric N Ceram Bulk-Fill, Beautifil Bulk-Fill Restorative)
Number of subjects: 10
Study 31373890 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill RBCs (Filtek Bulk-Fill Flowable, Tetric N Flow Bulk-Fill, Beautifil Bulk-Fill Flowable)
Number of subjects: 10
Study 31373890 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning in aqueous solutions (artificial saliva, 0.02 N citric acid, 50% ethanol-water solution)
Number of subjects: 10
Study 31587046 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP plus usual care
Number of subjects: 1121
Study 31587046 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) alone
Number of subjects: 1121
Study 28326568 — intervention group
Group type: EXPERIMENTAL
Intervention: eluxadoline 100 mg
Number of subjects: 2428
Study 28326568 — intervention group
Group type: EXPERIMENTAL
Intervention: eluxadoline 75 mg
Number of subjects: 2428
Study 28326568 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2428
Study 26381733 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (1 mA and 2 mA)
Number of subjects: 15
Study 26381733 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 15
Study 23725292 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping (DCM)
Number of subjects: 9
Study 23725292 — intervention group
Group type: COMPARATOR
Intervention: Comparison intervention using an alternative Qol assessment
Number of subjects: 9
Study 23725292 — intervention group
Group type: COMPARATOR
Intervention: Already implemented DCM
Number of subjects: 9
Study 21269421 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (physical therapy, NSAIDs, subacromial infiltration with local anesthetic and corticosteroids if indicated)
Number of subjects: 0
Study 21269421 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical reconstruction (acromioplasty with reconstruction of the rotator cuff tendon under general anesthesia and interscalenus plexus block)
Number of subjects: 0
Study 21269421 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment modalities (surgical and conservative)
Number of subjects: 0
Study 19782876 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17374061 — intervention group
Group type: EXPERIMENTAL
Intervention: Expensive cream in luxury jar (Group A)
Number of subjects: 80
Study 17374061 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular moisturizer in luxury jar (Group B)
Number of subjects: 80
Study 17374061 — intervention group
Group type: COMPARATOR
Intervention: Expensive cream in neutral jar (Group C)
Number of subjects: 80
Study 15309460 — intervention group
Group type: EXPERIMENTAL
Intervention: High-vegetable, fruit and fiber, low-fat diet intervention
Number of subjects: 52
Study 15309460 — intervention group
Group type: COMPARATOR
Intervention: General dietary guidelines for cancer prevention (Control)
Number of subjects: 52
Study 11915060 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intrabursal infusion of 0.5% bupivacaine and 2 mg morphine (5 mL bolus and 40 mL maintenance at 0.5 mL/h)
Number of subjects: 60
Study 11915060 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control group)
Number of subjects: 60
Study 9549817 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods for analysing incomplete longitudinal QOL data
Number of subjects: 0
Study 9549817 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 7796496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2099
Study 7796496 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus c7E3 Fab
Number of subjects: 2099
Study 7796496 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus plus infusion c7E3 Fab
Number of subjects: 2099
Study 2194849 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of monoethyl fumarate
Number of subjects: 12
Study 2194849 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic application of monoethyl fumarate
Number of subjects: 12
Study 2194849 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of monoethyl fumarate in urticaria pigmentosa
Number of subjects: 12
Study 694829 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 200
Study 694829 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin analogue
Number of subjects: 200
Study 30905157 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CCFM8610
Number of subjects: 0
Study 30905157 — intervention group
Group type: COMPARATOR
Intervention: FXR agonist GW4064
Number of subjects: 0
Study 30905157 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic pretreatment
Number of subjects: 0
Study 28770482 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoscopic inguinal lymphadenectomy (VIL)
Number of subjects: 102
Study 25868829 — intervention group
Group type: EXPERIMENTAL
Intervention: DUO (endoscopic dual balloon system plus diet and exercise)
Number of subjects: 326
Study 25868829 — intervention group
Group type: COMPARATOR
Intervention: DIET (sham endoscopy plus diet and exercise)
Number of subjects: 326
Study 23370674 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid infusion (1% HCl)
Number of subjects: 14
Study 23370674 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 14
Study 20643386 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory representations guiding attention with a probability of valid cues at 20%
Number of subjects: 0
Study 20643386 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory representations guiding attention with a probability of valid cues at 80%
Number of subjects: 0
Study 20643386 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions given to participants
Number of subjects: 0
Study 19661790 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic music video (TMV) intervention
Number of subjects: 12
Study 19661790 — intervention group
Group type: COMPARATOR
Intervention: Audio-book protocol (Control)
Number of subjects: 12
Study 17640582 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic procedures (balloon devices)
Number of subjects: 0
Study 15573923 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-filled balloon esophageal and anorectal catheters
Number of subjects: 10
Study 15573923 — intervention group
Group type: COMPARATOR
Intervention: Solid-state esophageal catheter
Number of subjects: 10
Study 15573923 — intervention group
Group type: COMPARATOR
Intervention: Water-perfused anorectal catheter
Number of subjects: 10
Study 11564022 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension using Prolene mesh and titanium tacks
Number of subjects: 87
Study 11564022 — intervention group
Group type: COMPARATOR
Intervention: Open Burch colposuspension
Number of subjects: 87
Study 9773721 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro (Humalog)
Number of subjects: 10
Study 9773721 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular human insulin (Humulin R)
Number of subjects: 10
Study 9773721 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (nondiabetic)
Number of subjects: 10
Study 8145910 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) 0.4 g/kg body weight per day for 5 consecutive days
Number of subjects: 12
Study 8145910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3391879 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin acistrate (EA) 400 mg tid
Number of subjects: 183
Study 3391879 — intervention group
Group type: COMPARATOR
Intervention: Enterocoated erythromycin base (EB) 500 mg tid
Number of subjects: 183
Study 31489559 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support intervention (two core calls in the week following an ED visit)
Number of subjects: 513
Study 31489559 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support intervention
Number of subjects: 513
Study 30155718 — intervention group
Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 281
Study 30155718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 29269731 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate ketogenic (LCK) diet, n=16
Number of subjects: 34
Study 29269731 — intervention group
Group type: COMPARATOR
Intervention: Moderate-carbohydrate, calorie-restricted, low-fat (MCCR) diet, n=18
Number of subjects: 34
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycaemic events in Type-1 diabetes
Number of subjects: 553
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycaemic events in Type-2 diabetes
Number of subjects: 553
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of hypoglycaemic symptoms in Type-1 diabetes
Number of subjects: 553
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of hypoglycaemic symptoms in Type-2 diabetes
Number of subjects: 553
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication with physicians about hypoglycaemic events in Type-1 diabetes
Number of subjects: 553
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication with physicians about hypoglycaemic events in Type-2 diabetes
Number of subjects: 553
Study 25421366 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related impacts of hypoglycaemic events
Number of subjects: 553
Study 23802562 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized information provided by gynecologists
Number of subjects: 9507
Study 21443599 — intervention group
Group type: EXPERIMENTAL
Intervention: Alitretinoin 20 mg, once daily for 14 days
Number of subjects: 24
Study 21443599 — intervention group
Group type: EXPERIMENTAL
Intervention: Alitretinoin 40 mg, once daily for 14 days
Number of subjects: 24
Study 21443599 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 19304097 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vacuum group (vacuum 200 mm Hg, flow rate 20 cc/min)
Number of subjects: 60
Study 19304097 — intervention group
Group type: COMPARATOR
Intervention: High vacuum group (vacuum 400 mm Hg, flow rate 40 cc/min)
Number of subjects: 60
Study 19304097 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vacuum group
Number of subjects: 60
Study 19304097 — intervention group
Group type: COMPARATOR
Intervention: High vacuum group
Number of subjects: 60
Study 19304097 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 16387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cardioplegia (BC)
Number of subjects: 30
Study 16387508 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (CC)
Number of subjects: 30
Study 16387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CC and BC)
Number of subjects: 30
Study 16387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative oxygen supplementation
Number of subjects: 30
Study 16387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of CC and BC
Number of subjects: 30
Study 14579980 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO-ORS in group A (well nourished)
Number of subjects: 50
Study 14579980 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO-ORS in group B (malnourished)
Number of subjects: 50
Study 14579980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypokalaemia in group A (well nourished)
Number of subjects: 50
Study 14579980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypokalaemia in group B (malnourished)
Number of subjects: 50
Study 11215011 — intervention group
Group type: EXPERIMENTAL
Intervention: Photography as an aid to skin examinations
Number of subjects: 0
Study 11215011 — intervention group
Group type: COMPARATOR
Intervention: Control group (no photographs received)
Number of subjects: 0
Study 8602598 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum arabic (50 g/d)
Number of subjects: 16
Study 8602598 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 g pectin/d)
Number of subjects: 16
Study 1418062 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol 200 micrograms
Number of subjects: 30
Study 1418062 — intervention group
Group type: EXPERIMENTAL
Intervention: bitolterol mesilate 740 micrograms
Number of subjects: 30
Study 6372073 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine 50 mg at night
Number of subjects: 36
Study 6372073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 29668213 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR tools and patient engagement for high-risk patients
Number of subjects: 7691
Study 29668213 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR tools and patient engagement for low-risk patients
Number of subjects: 7691
Study 29668213 — intervention group
Group type: COMPARATOR
Intervention: Prescription of ACE inhibitor or ARB for high-risk patients
Number of subjects: 7691
Study 29668213 — intervention group
Group type: COMPARATOR
Intervention: Prescription of ACE inhibitor or ARB for low-risk patients
Number of subjects: 7691
Study 26913411 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex)
Number of subjects: 30
Study 26913411 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 30
Study 25241986 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (75-225 mg/day)
Number of subjects: 249
Study 25241986 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day)
Number of subjects: 249
Study 25241986 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran (100 mg/day)
Number of subjects: 249
Study 22579379 — intervention group
Group type: COMPARATOR
Intervention: EBRT 39 Gy in 13 fractions
Number of subjects: 88
Study 22579379 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT + CXRT boost, 85 Gy in three fractions
Number of subjects: 88
Study 22579379 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with complete CR
Number of subjects: 88
Study 22579379 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CR ≥ 50%
Number of subjects: 88
Study 22579379 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CR <50%
Number of subjects: 88